Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2012 Apr;36(4):534-43.
doi: 10.1097/PAS.0b013e318240590a.

Gamma heavy-chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases

Affiliations
Multicenter Study

Gamma heavy-chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases

Shannon Bieliauskas et al. Am J Surg Pathol. 2012 Apr.

Abstract

Gamma heavy-chain disease (gHCD) is defined as a lymphoplasmacytic neoplasm that produces an abnormally truncated immunoglobulin gamma heavy-chain protein that lacks associated light chains. There is scant information in the literature regarding the morphologic findings in this rare disorder, but cases have often been reported to resemble lymphoplasmacytic lymphoma (LPL). To clarify the spectrum of lymphoproliferative disorders that may be associated with gHCD, this study reports the clinical, morphologic, and phenotypic findings in 13 cases of gHCD involving lymph nodes (n=7), spleen (n=2), bone marrow (n=8), or other extranodal tissue biopsies (n=3). Clinically, patients showed a female predominance (85%) with frequent occurrence of autoimmune disease (69%). Histologically, 8 cases (61%) contained a morphologically similar neoplasm of small lymphocytes, plasmacytoid lymphocytes, and plasma cells that was difficult to classify with certainty, whereas the remaining 5 cases (39%) showed the typical features of one of several other well-defined entities in the 2008 WHO classification. This report demonstrates that gHCD is associated with a variety of underlying lymphoproliferative disorders but most often shows features that overlap with cases previously reported as "vaguely nodular, polymorphous" LPL. These findings also provide practical guidance for the routine evaluation of small B-cell neoplasms with plasmacytic differentiation that could represent a heavy-chain disease and give suggestions for an improved approach to the WHO classification of gHCD.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
This group I case (case 8) shows an interfollicular and diffuse infiltrate of small lymphocytes, plasmacytoid cells, and plasma cells (A, H&E; B, H&E). By immunohistochemistry, numerous IgG-positive cells (C) that lack kappa and lambda light-chain expression (D) are seen.
FIGURE 2
FIGURE 2
A, This group I case (case 10) displays splenomegaly with a red pulp and white pulp infiltrate of small lymphocytes, plasmacytoid cells, and plasma cells. White pulp nodules suggestive of SMZL were not identified (H&E). B, In this group I case (case 9), a submandibular salivary gland mass contained a diffuse and interfollicular infiltrate of small lymphocytes, plasmacytoid cells, and plasma cells. Overt monocytoid morphology and lymphoepithelial lesions typical of salivary MALT lymphomas were not identified (H&E).
FIGURE 3
FIGURE 3
A–C, This group II case (case 5) shows white pulp that is expanded (A, H&E) by nodules with dark cores of small lymphocytes and paler outer zones of marginal-zone cells and plasma cells (B, H&E). The pale rims of marginal-zone cells and plasma cells are positive for IgG (C) and lack detectable kappa and lambda staining by immunohistochemistry or in situ hybridization (not shown). D–F, In this group II case (case 11) a thyroid specimen shows colonized germinal centers surrounded by an interfollicular infiltrate of small lymphocytes and plasma cells (D, H&E; E, H&E). An IgG stain highlights lymphoepithelial lesions (F).
FIGURE 4
FIGURE 4
A, A bone marrow core biopsy from a group I case (case 4) shows an aggregate of predominantly small lymphocytes (H&E). B, An IgG immunostain highlights positive cells within the aggregates that appeared to lack kappa or lambda light chains (not shown).

Similar articles

Cited by

References

    1. Al-Saleem T, Al-Mondhiry H. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. Blood. 2005;105:2274–2280. - PubMed
    1. Amakawa R, Ohno H, Fukuhara S. t(9;14)(p13;q32) involving the PAX-5 gene: a unique subtype of 14q32 translocation in B cell non-Hodgkin’s lymphoma. Int J Hematol. 1999;69:65–69. - PubMed
    1. Andriko JA, Swerdlow SH, Aguilera NI, et al. Is lymphoplasmacytic lymphoma/immunocytoma a distinct entity? A clinicopathologic study of 20 cases. Am J Surg Pathol. 2001;25:742–751. - PubMed
    1. Cogne M, Bakhshi A, Korsmeyer SJ, et al. Gene mutations and alternate RNA splicing result in truncated Ig L chains in human gamma H chain disease. J Immunol. 1988;141:1738–1744. - PubMed
    1. Cook JR, Aguilera NI, Reshmi-Skarja S, et al. Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14) Hum Pathol. 2004;35:447–454. - PubMed

Publication types

MeSH terms

Substances